As of 2025-12-24, the Relative Valuation of Altimmune Inc (ALT) is (10.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Altimmune Inc based on Relative Valuation is -366.5%.
The range of the Relative Valuation is (8.60) - (11.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 19.5x | 18.0x |
| Forward P/E multiples | 14.6x - 21.9x | 18.3x |
| Fair Price | (8.60) - (11.45) | (10.66) |
| Upside | -315.0% - -386.3% | -366.5% |
| Date | P/E |
| 2025-12-22 | -7.05 |
| 2025-12-19 | -6.64 |
| 2025-12-18 | -8.60 |
| 2025-12-17 | -8.67 |
| 2025-12-16 | -8.56 |
| 2025-12-15 | -8.99 |
| 2025-12-12 | -8.97 |
| 2025-12-11 | -9.09 |
| 2025-12-10 | -9.24 |
| 2025-12-09 | -9.40 |
| 2025-12-08 | -9.55 |
| 2025-12-05 | -8.92 |
| 2025-12-04 | -9.04 |
| 2025-12-03 | -8.70 |
| 2025-12-02 | -8.10 |
| 2025-12-01 | -8.39 |
| 2025-11-28 | -8.96 |
| 2025-11-26 | -8.80 |
| 2025-11-25 | -8.75 |
| 2025-11-24 | -8.68 |
| 2025-11-21 | -8.19 |
| 2025-11-20 | -7.61 |
| 2025-11-19 | -7.81 |
| 2025-11-18 | -7.92 |
| 2025-11-17 | -7.13 |
| 2025-11-14 | -7.10 |
| 2025-11-13 | -6.91 |
| 2025-11-12 | -7.20 |
| 2025-11-11 | -7.29 |
| 2025-11-10 | -7.25 |
| 2025-11-07 | -7.00 |
| 2025-11-06 | -6.71 |
| 2025-11-05 | -6.38 |
| 2025-11-04 | -6.40 |
| 2025-11-03 | -6.74 |
| 2025-10-31 | -6.90 |
| 2025-10-30 | -6.93 |
| 2025-10-29 | -6.81 |
| 2025-10-28 | -6.91 |
| 2025-10-27 | -7.05 |
| 2025-10-24 | -6.73 |
| 2025-10-23 | -6.74 |
| 2025-10-22 | -6.64 |
| 2025-10-21 | -6.88 |
| 2025-10-20 | -6.81 |
| 2025-10-17 | -6.52 |
| 2025-10-16 | -6.62 |
| 2025-10-15 | -6.81 |
| 2025-10-14 | -6.76 |
| 2025-10-13 | -6.81 |